The relationship between symptomatic and functional changes of Korean children and adolescents with attention deficit hyperactivity disorder treated with OROS methylphenidate

被引：0
|
作者：
Lee, S. [1 ]
Kim, E. [1 ]
Cheon, K. [1 ]
Song, D. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2015年 / 24卷
关键词：
OROS-MPH; ADHD; Symptoms; Functioning; Life Participation Scale;
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
PS-109
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [31] Monitoring Social Behavior Using the Child Conflict Index in Children with Attention Deficit Hyperactivity Disorder (ADHD) Treated with OROS Methylphenidate
    Starr, Harriette L.
    Armstrong, Robert B.
    Damaraju, C. V.
    Ascher, Steve
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 533 - 534
  • [32] Experiences of children and adolescents with attention-deficit/hyperactivity disorder taking methylphenidate
    Jacobs, Delphine
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2023, 65 (12): : 1587 - 1595
  • [33] Effectiveness and safety of the once-daily OROS formulation of methylphenidate in adolescents with attention-deficit/hyperactivity disorder
    Biederman, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S448 - S448
  • [34] Effects of Iron Supplementation on Attention Deficit Hyperactivity Disorder in Children Treated with Methylphenidate
    Tohidi, Sepehr
    Bidabadi, Elham
    Khosousi, Mohammad-Javad
    Amoukhteh, Melika
    Kousha, Maryam
    Mashouf, Parham
    Shahraki, Tamkin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2021, 19 (04) : 712 - 720
  • [35] Methylphenidate use in children with attention deficit hyperactivity disorder
    Machado, Felipe Salles Neves
    Caetano, Sheila Cavalcante
    Hounie, Ana Gabriela
    Scivoletto, Sandra
    Muszkat, Mauro
    Gattas, Ivete Gianfaldoni
    Casella, Erasmo Barbante
    de Andrade, Enio Roberto
    Polanczyk, Guilherme Vanoni
    do Rosario, Maria Conceicao
    REVISTA DE SAUDE PUBLICA, 2015, 49
  • [36] Once-daily OROS® methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder
    McGough, James J.
    McBurnett, Keith
    Bukstein, Oscar
    Wilens, Timoth E.
    Greenhill, Laurence
    Lerner, Marc
    Stein, Mark
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (03) : 351 - 356
  • [37] Manganese in Children with Attention-Deficit/Hyperactivity Disorder: Relationship with Methylphenidate Exposure
    Farias, Antonio C.
    Cunha, Alexandre
    Benko, Cassia R.
    McCracken, James T.
    Costa, Maria T.
    Farias, Lucilene G.
    Cordeiro, Mara L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (02) : 113 - 118
  • [38] Examining the relationship between Attention-Deficit/Hyperactivity Disorder and overweight in children and adolescents
    Erhart, Michael
    Herpertz-Dahlmann, Beate
    Wille, Nora
    Sawitzky-Rose, Barbara
    Hoelling, Heike
    Ravens-Sieberer, Ulrike
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2012, 21 (01) : 39 - 49
  • [39] Examining the relationship between Attention-Deficit/Hyperactivity Disorder and overweight in children and adolescents
    Michael Erhart
    Beate Herpertz-Dahlmann
    Nora Wille
    Barbara Sawitzky-Rose
    Heike Hölling
    Ulrike Ravens-Sieberer
    European Child & Adolescent Psychiatry, 2012, 21 : 39 - 49
  • [40] Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in children and adolescents with attention deficit hyperactivity disorder
    Hennissen, Leonie
    Bakker, Mireille
    Buitelaar, Jan K.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S50 - S50
12345